Thomas Asklund

1.5k total citations
30 papers, 1.0k citations indexed

About

Thomas Asklund is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Asklund has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Genetics and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Asklund's work include Glioma Diagnosis and Treatment (9 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Medical Imaging Techniques and Applications (6 papers). Thomas Asklund is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Medical Imaging Techniques and Applications (6 papers). Thomas Asklund collaborates with scholars based in Sweden, Denmark and Netherlands. Thomas Asklund's co-authors include Tufve Nyholm, Anders Garpebring, Roger Henriksson, Patrik Brynolfsson, Adam Johansson, Mikael Karlsson, Hans Skovgaard Poulsen, Tommy Löfstedt, Jun Yu and Johan Trygg and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Thomas Asklund

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Asklund Sweden 18 504 231 208 172 148 30 1.0k
Hassan Bagher‐Ebadian United States 19 821 1.6× 201 0.9× 61 0.3× 130 0.8× 47 0.3× 79 1.2k
Fulvio Zaccagna Italy 22 824 1.6× 80 0.3× 93 0.4× 497 2.9× 45 0.3× 83 1.6k
John A. Kennedy Israel 21 304 0.6× 54 0.2× 112 0.5× 64 0.4× 66 0.4× 69 1.4k
Bob L. Hou United States 16 513 1.0× 433 1.9× 134 0.6× 220 1.3× 24 0.2× 32 1.1k
Peter McLaren Black United States 18 419 0.8× 263 1.1× 283 1.4× 114 0.7× 29 0.2× 38 1.6k
Ingerid Reinertsen Norway 21 613 1.2× 472 2.0× 39 0.2× 137 0.8× 59 0.4× 56 1.2k
Danny Tat Ming Chan Hong Kong 23 194 0.4× 394 1.7× 413 2.0× 241 1.4× 22 0.1× 63 1.5k
Naoki Kubo Japan 22 365 0.7× 55 0.2× 772 3.7× 132 0.8× 111 0.8× 82 1.6k
Ilja Bezrukov Germany 18 889 1.8× 35 0.2× 109 0.5× 117 0.7× 146 1.0× 36 1.3k
Jifke F. Veenland Netherlands 22 733 1.5× 32 0.1× 81 0.4× 418 2.4× 99 0.7× 51 1.4k

Countries citing papers authored by Thomas Asklund

Since Specialization
Citations

This map shows the geographic impact of Thomas Asklund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Asklund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Asklund more than expected).

Fields of papers citing papers by Thomas Asklund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Asklund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Asklund. The network helps show where Thomas Asklund may publish in the future.

Co-authorship network of co-authors of Thomas Asklund

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Asklund. A scholar is included among the top collaborators of Thomas Asklund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Asklund. Thomas Asklund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asklund, Thomas, et al.. (2020). Intratumoral retrograde microdialysis treatment of high-grade glioma with cisplatin. Acta Neurochirurgica. 162(12). 3043–3053. 5 indexed citations
2.
Löfstedt, Tommy, Patrik Brynolfsson, Thomas Asklund, Tufve Nyholm, & Anders Garpebring. (2019). Gray-level invariant Haralick texture features. PLoS ONE. 14(2). e0212110–e0212110. 137 indexed citations
3.
Björkblom, Benny, Pär Jonsson, Per Bergström, et al.. (2019). Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma. British Journal of Cancer. 122(2). 221–232. 24 indexed citations
4.
Sandström, Maria, et al.. (2017). A Retrospective Evaluation of Bevacizumab Treatment in Patients with Progressive Malignant Glioma in Northern Sweden. Anticancer Research. 37(4). 1869–1874. 3 indexed citations
5.
Brynolfsson, Patrik, David Nilsson, Turid Torheim, et al.. (2017). Haralick texture features from apparent diffusion coefficient (ADC) MRI images depend on imaging and pre-processing parameters. Scientific Reports. 7(1). 4041–4041. 117 indexed citations
6.
Malmström, Annika, Hans Skovgaard Poulsen, Bjørn Henning Grønberg, et al.. (2017). Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial. Acta Oncologica. 56(12). 1776–1785. 16 indexed citations
7.
Johansson, Adam, Anders Garpebring, Thomas Asklund, & Tufve Nyholm. (2014). CT substitutes derived from MR images reconstructed with parallel imaging. Medical Physics. 41(8Part1). 82302–82302. 23 indexed citations
8.
Asklund, Thomas, Annika Malmström, Michael Bergqvist, Ove Björ, & Roger Henriksson. (2014). Brain tumors in Sweden: Data from a population-based registry 1999–2012. Acta Oncologica. 54(3). 377–384. 50 indexed citations
9.
Brynolfsson, Patrik, David Nilsson, Roger Henriksson, et al.. (2014). ADC texture—An imaging biomarker for high‐grade glioma?. Medical Physics. 41(10). 101903–101903. 65 indexed citations
10.
11.
Jönsson, Joakim, Adam Johansson, Karin Söderström, Thomas Asklund, & Tufve Nyholm. (2013). Treatment planning of intracranial targets on MRI derived substitute CT data. Radiotherapy and Oncology. 108(1). 118–122. 44 indexed citations
12.
Kesek, Milos, Tufve Nyholm, & Thomas Asklund. (2012). Radiotherapy and pacemaker: 80 Gy to target close to the device may be feasible. EP Europace. 14(11). 1595–1595. 13 indexed citations
13.
Johansson, Adam, Mikael Karlsson, Jun Yu, Thomas Asklund, & Tufve Nyholm. (2012). Voxel‐wise uncertainty in CT substitute derived from MRI. Medical Physics. 39(6Part1). 3283–3290. 65 indexed citations
14.
Henriksson, Roger, Thomas Asklund, & Hans Skovgaard Poulsen. (2011). Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review. Journal of Neuro-Oncology. 104(3). 639–646. 121 indexed citations
15.
Asklund, Thomas, Torsten Danfors, & Roger Henriksson. (2011). PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma. Clinical Neuropathology. 30(9). 242–246. 8 indexed citations
16.
Garpebring, Anders, Ronnie Wirestam, Jun Yu, Thomas Asklund, & Mikael Karlsson. (2011). Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations. Magnetic Resonance Materials in Physics Biology and Medicine. 24(4). 233–245. 25 indexed citations
17.
Malmström, Annika, Hemming Poulsen, Giuseppe Stragliotto, et al.. (2010). NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY in NEURO-ONCOLOGY, vol 12, issue , pp 39-40. 12. 39–40. 1 indexed citations
18.
Khan, Zahidul Islam, et al.. (2007). HDAC inhibition amplifies gap junction communication in neural progenitors: Potential for cell-mediated enzyme prodrug therapy. Experimental Cell Research. 313(13). 2958–2967. 25 indexed citations
19.
Asklund, Thomas, Ioulia B. Appelskog, Ole Ammerpohl, Tomas J. Ekström, & Per Almqvist. (2004). Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. European Journal of Cancer. 40(7). 1073–1081. 47 indexed citations
20.
Asklund, Thomas, Ioulia B. Appelskog, Ole Ammerpohl, et al.. (2003). Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Experimental Cell Research. 284(2). 183–193. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Bagher‐Ebadian Breakdown of academic impact, for papers by Fulvio Zaccagna Breakdown of academic impact, for papers by John A. Kennedy Breakdown of academic impact, for papers by Bob L. Hou Breakdown of academic impact, for papers by Peter McLaren Black Breakdown of academic impact, for papers by Ingerid Reinertsen Breakdown of academic impact, for papers by Danny Tat Ming Chan Breakdown of academic impact, for papers by Naoki Kubo Breakdown of academic impact, for papers by Ilja Bezrukov Breakdown of academic impact, for papers by Jifke F. Veenland
Rankless by CCL
2026